BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26586370)

  • 1. A preliminary report of breast cancer screening by positron emission mammography.
    Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
    Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
    Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
    Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
    Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
    Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
    AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
    Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
    J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
    Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
    Peng NJ; Chou CP; Pan HB; Chang TH; Hu C; Chiu YL; Fu TY; Chang HT
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):445-452. PubMed ID: 25872026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
    Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
    Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
    Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
    Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS
    Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.
    Kaida H; Ishibashi M; Fujii T; Kurata S; Ogo E; Tanaka M; Hayabuchi N
    Ann Nucl Med; 2008 Feb; 22(2):95-101. PubMed ID: 18311533
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Watanabe G; Itoh M; Duan X; Watabe H; Mori N; Tada H; Suzuki A; Miyashita M; Ohuchi N; Ishida T
    Eur Radiol; 2018 May; 28(5):1929-1937. PubMed ID: 29218614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
    Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
    Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
    Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
    AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A false-positive fluorodeoxyglucose positron emission tomography (FDG-PET) imaging result for a patient after augmentation mammaplasty.
    Kobe K; Chin T; Aoki R; Hyakusoku H
    Aesthetic Plast Surg; 2009 Jul; 33(4):611-5. PubMed ID: 19421809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
    Bitencourt AG; Lima EN; Macedo BR; Conrado JL; Marques EF; Chojniak R
    Eur Radiol; 2017 May; 27(5):1893-1900. PubMed ID: 27585658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
    Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
    Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.